Lysosomal Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lysosomal therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lysosomal Therapeutics Today - Breaking & Trending Today

Ten63 Therapeutics Elects Steve Hall as Independent Director

/PRNewswire/ Ten63 announces the election of Steve Hall to its board of directors. Hall, who retired as a Partner at LV Management Group (Lilly Ventures). ....

Steve Hall , Marcel Frenkel , Venture Investor Brings Extensive Experience Launching Companies , Lv Management Group Lilly Ventures , Bristol Myers Squibb , New Drug Discovery , Lilly Ventures , Site Director , Cerulean Therapeutics , Hydra Biosciences , Kymera Therapeutics , Lysosomal Therapeutics , Nimbus Therapeutics , Ten63 Therapeutics ,

Biopharma is Tackling Misfolding Proteins in Parkinson's Disease

Parkinson’s disease has been immensely challenging for biotech companies. A high rate of late-stage attrition in trials has led to a lack of approved therapies for the disease. ....

Northwestern University , United States , United Kingdom , Sumitomo Dainippon Pharma , Vanqua Bio , Eli Lilly , Eric Richman , Sunovion Pharmaceuticals , Boehringer Ingelheim , Society For Neuroscience Annual Meeting , University Of Maryland School Medicine , Parkinson Foundation , Anavex Life Sciences , Neuroscience Annual Meeting , Gain Therapeutics , Maryland School , Structurally Targeted Allosteric Regulators , Q State Biosciences , Lysosomal Therapeutics , Prevail Therapeutics , Big Pharma , Chase Therapeutics , Neuropore Therapies , Iopharma Is Tackling Misfolding Proteins In Parkinsons Disease ,

Neuro startup Vanqua Bio emerges with $85M and a first focus on Parkinson's

Neuro startup Vanqua Bio emerges with $85M and a first focus on Parkinson's
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Dimitri Krainc , Vanqua Bio , Eli Lilly , Osage University , Northwestern University Feinberg School Of Medicine , Lysosomal Therapeutics , Northwestern University , Feinberg School , Surveyor Capital , Avoro Ventures , Casdin Capital , Logos Capital , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , எலி லில்லி , ஓஸாகெ பல்கலைக்கழகம் , வடமேற்கு பல்கலைக்கழகம் ஃபைன்பெர்க் பள்ளி ஆஃப் மருந்து , வடமேற்கு பல்கலைக்கழகம் , ஃபைன்பெர்க் பள்ளி , நிலமளப்போர் மூலதனம் , லோகோக்கள் மூலதனம் ,

Expansion Therapeutics Names Valerie Cullen, Ph.D., Senior Vice President of Research

Published: May 06, 2021

BOSTON (BUSINESS WIRE) Expansion Therapeutics., a biotechnology company advancing transformative medicines to patients with RNA-mediated diseases, today announced the appointment of Valerie Cullen, Ph.D., to Senior Vice President of Research.
“Valerie’s depth and breadth of research experience in drug development for neurological diseases, including leading complex programs at the intersection of research, translation and clinical development, will be tremendously valuable to our company,” said Renato Skerlj, Chief Executive Officer and President of Expansion Therapeutics. “We are fortunate to have her leadership as we advance our portfolio of small molecule medicines to treat RNA-mediated diseases in patients who currently have limited or no treatment options.” ....

United States , City Of , United Kingdom , Proclara Biosciences , Valerie Cullen , Renato Skerlj , Matthewd Disney , Scripps Research Institute , King College London , Program Lead At Lysosomal Therapeutics Inc , University College Dublin , Harvard Medical School , Senior Vice President , Chief Executive Officer , Vice President , Program Lead , Lysosomal Therapeutics , Link Medicine , College London , Harvard Medical , ஒன்றுபட்டது மாநிலங்களில் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , வலேரி கல்லன் , ஸ்கிரிப்ட்கள் ஆராய்ச்சி நிறுவனம் , கிங் கல்லூரி லண்டன் ,